Diabetes is not a single disease with a single cause. Type 1 diabetes is caused by autoimmune destruction of pancreatic beta cells. Type 2 diabetes is caused by insulin resistance combined with progressive beta-cell decline. Gestational diabetes is caused by placental hormones overwhelming maternal insulin secretion. Secondary diabetes can be caused by pancreatic disease, endocrine disorders, medications, or genetic syndromes. Identifying the cause matters because it guides treatment, prognosis, and family screening.
Type 1 Diabetes
Type 1 diabetes is caused by autoimmune destruction of the insulin-producing beta cells in the pancreatic islets of Langerhans. Without functioning beta cells, the body cannot produce enough insulin to control blood glucose.
Genetic Susceptibility
- HLA-DR3 and HLA-DR4 alleles confer the strongest genetic risk
- HLA-DR3/DR4 heterozygotes have the highest risk among genotypes
- Non-HLA genes — INS, PTPN22, IL2RA, CTLA4 — contribute
- ~50 percent monozygotic twin concordance — genetics is necessary but not sufficient
Environmental Triggers Studied
- Enteroviruses, particularly coxsackievirus B
- Other viral infections, possibly including SARS-CoV-2
- Gut microbiome alterations
- Early infant feeding patterns
- Vitamin D status
- Cesarean delivery and antibiotic exposure
Disease Stages
- Stage 1: 2 or more autoantibodies, normal glucose
- Stage 2: 2 or more autoantibodies, dysglycemia, no symptoms
- Stage 3: clinical diabetes with symptoms
Teplizumab can delay progression from stage 2 to stage 3 by approximately 2 years in screened relatives.
Type 2 Diabetes
Type 2 diabetes is caused by a combination of insulin resistance in muscle, fat, and liver, plus progressive failure of beta cells to keep up with the demand for insulin. Both elements are usually present.
Risk Factors
| Factor | Effect on Risk |
|---|---|
| Family history | Major — 2 to 6 times higher risk |
| Age over 45 | Increases steadily with age |
| Overweight or obesity | Strong driver of insulin resistance |
| Physical inactivity | Independent risk factor |
| South Asian, African, Hispanic, Pacific Islander ancestry | Higher baseline risk at lower BMI |
| Prior gestational diabetes | ~50 percent develop type 2 within 10 years |
| Polycystic ovary syndrome | Insulin resistance phenotype |
| Sleep apnea | Insulin resistance and inflammation |
| Sleep deprivation or shift work | Worsens glucose tolerance |
| Smoking | Increases insulin resistance |
Pathophysiology
- Insulin resistance: muscle, fat, and liver respond less to insulin
- Hepatic glucose production is not suppressed normally
- Beta cells initially compensate by producing more insulin
- Over years, beta-cell function declines — UKPDS showed ~50 percent function at diagnosis
- Hyperglycemia eventually develops when compensation fails
Gestational Diabetes
Gestational diabetes is caused by placental hormones — including human placental lactogen, cortisol, and progesterone — that promote insulin resistance to provide glucose for the growing fetus. In women whose beta cells cannot fully compensate, hyperglycemia results.
- Usually develops in the second or third trimester
- Resolves after delivery in most cases
- ~50 percent develop type 2 diabetes within 10 years
- Risk factors: age over 25, family history, overweight, prior gestational diabetes, ethnicity, polycystic ovary syndrome
Secondary Diabetes
Pancreatic Disease (Type 3c)
- Chronic pancreatitis
- Pancreatic cancer
- Cystic fibrosis
- Hemochromatosis (bronze diabetes)
- Post-pancreatectomy
Endocrine Disorders
- Cushing syndrome (cortisol excess)
- Acromegaly (growth hormone excess)
- Pheochromocytoma (catecholamines)
- Glucagonoma
- Hyperthyroidism
Drug-Induced
- Corticosteroids — predictable and dose-dependent
- Tacrolimus, cyclosporine, mTOR inhibitors after transplant
- Immune checkpoint inhibitors — autoimmune beta-cell destruction
- Atypical antipsychotics — olanzapine, clozapine
- Thiazide diuretics, statins (modest effect)
- Some chemotherapy
- Antiretrovirals
Genetic Syndromes
- Down syndrome
- Klinefelter syndrome
- Turner syndrome
- Wolfram syndrome (DIDMOAD)
- Prader-Willi syndrome
Monogenic Diabetes
MODY (Maturity-Onset Diabetes of the Young)
- Autosomal dominant single-gene defects
- HNF1A, HNF4A, GCK, HNF1B, and others
- Typically presents before age 25
- Strong family history through multiple generations
- Often misdiagnosed as type 1 or type 2
- Treatment depends on subtype — GCK MODY often needs no medication, HNF1A responds to sulfonylureas
Neonatal Diabetes
- Diagnosed before 6 months of age
- KCNJ11 and ABCC8 mutations — often respond to sulfonylureas
- Can be permanent or transient
Mitochondrial Diabetes
- m.3243A>G mutation most common
- Maternally inherited
- Often accompanied by sensorineural hearing loss
- MIDD: maternally inherited diabetes and deafness
LADA (Latent Autoimmune Diabetes in Adults)
- Adult-onset autoimmune diabetes with slower progression than classic type 1
- GAD-65 antibody positive in most cases
- Often misdiagnosed initially as type 2
- May respond to oral agents at first but progresses to insulin dependence
Type 1.5 and Other Hybrid Phenotypes
Some patients do not fit cleanly into the standard categories — for example, an overweight adult with positive autoantibodies (sometimes called type 1.5) or a lean person with apparent type 2 features. Antibody and C-peptide testing helps classify these cases. See our overview of diabetes classification for detail.
Comparison Across Types
| Type | Primary Cause | Typical Age | BMI | Insulin Need |
|---|---|---|---|---|
| Type 1 | Autoimmune beta-cell destruction | Childhood and young adult, can be any age | Often normal or low | From diagnosis |
| Type 2 | Insulin resistance + beta-cell decline | Usually over 40, increasingly younger | Often elevated | Sometimes; many years in |
| Gestational | Placental hormones | Pregnancy | Variable | Sometimes |
| LADA | Slower autoimmune | Adult | Often normal | Within months to years |
| MODY | Single-gene defect | Often under 25 | Often normal | Depends on subtype |
| Type 3c | Pancreatic damage | Variable | Variable | Often early |
| Drug-induced | Specific medication | Any | Variable | Variable |
Why Cause Matters
- Treatment differs — autoimmune forms usually need insulin; some MODY forms respond to sulfonylureas
- Family screening — relatives of MODY or type 1 patients may benefit from testing
- Pregnancy planning — pre-conception A1C optimization differs by type
- Complications screening — onset, progression, and comorbidities vary
- Avoiding misdiagnosis — LADA mistaken for type 2 leads to delayed insulin and worse outcomes
Related Reading
See our deeper guides on diabetes classification, diabetes diagnostic criteria, beta cells and diabetes, and our prediabetes basics hub.
The Bottom Line
Diabetes is an umbrella term for several distinct diseases with different causes. Type 1 is autoimmune. Type 2 is driven by insulin resistance and beta-cell decline. Gestational diabetes is caused by pregnancy hormones. Secondary forms result from pancreatic disease, endocrine disorders, drugs, or genetic syndromes. Monogenic and mitochondrial forms also exist. Identifying the cause matters for treatment, family screening, and prognosis. People with new diabetes or unclear classification should talk to their clinician about whether autoantibody panels, C-peptide, or genetic testing is appropriate.
